Search results
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop...
CNBC· 2 weeks agoThe licensing agreement will allow Novavax to lift its "going concern" warning, which it first...
Novavax stock soars 40% on Sanofi partnership By Investing.com
Investing.com· 2 weeks agoFor the first quarter, Novavax reported a first-quarter loss per share of $1.05, wider than the...
Novavax Stock Just Tripled. Is It Too Late to Buy?
The Motley Fool via AOL· 6 days agoand made significant progress in reducing research and development and general expenses by more than $500 million last year compared ...
Could Novavax Become the Next Moderna? | The Motley Fool
The Motley Fool· 4 days agoNovavax (NVAX -9.65%) and Moderna (MRNA 0.17%) both entered the coronavirus vaccine race around the...
If You'd Invested $10,000 in Novavax a Year Ago, This Is How Much You'd Have Now | The Motley Fool
The Motley Fool· 5 days agoIf you'd invested $10,000 in Novavax (NVAX 9.26%) a year ago, you would have made a risky bet. Prior...
Why Novavax Stock More Than Doubled Today | The Motley Fool
The Motley Fool· 2 weeks agoThe company is partnering with fellow pharmaceutical company Sanofi (SNY 1.21%) to market Novavax's...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 2 days agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus ...
Up 3x In A Week, Will Novavax Stock Continue To See Higher Levels?
Forbes· 4 days agoNVAX stock was trading at around $51 in early June 2022, just before the Fed started increasing...
Roaring Kitty's Rally Cry: 3 Meme Stocks to Pounce On Now
InvestorPlace· 15 hours agoGameStop (NYSE:GME) and AMC (NYSE:AMC) meme stocks rose substantially last week, gaining over 70%. The return of ‘Roaring Kitty’, prominent investor Keith Gill, has traders ...
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 5 days agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...